Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Overcoming obstacles to medicines access
As the 2020 World Health Assembly re-convenes in Geneva, an international coalition of think tanks urges governments to commit to simple reforms to accelerate access to medicines, including those in the process of being developed for Covid-19.